Position in LLY
as of Jun 30, 2026
· filed Jul 9, 2026
Position Value
$1,119,068
+$282,998 QoQ
Shares Held
933
+2.6% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.78%
of 13F equity value
Holder Rank
#3,038
of 4,621 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Financial Management Professionals, Inc. holds $5,803,019 across 15 Drug Manufacturers - General names. LLY ranks #2 (19.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
|
6,071 | $1,527,706 | |
| 2 | LLY |
ELI LILLY & Co
This page
|
933 | $1,119,068 | |
| 3 | GILD |
Gilead Sciences, Inc.
|
7,239 | $914,575 | |
| 4 | JNJ |
Johnson & Johnson
|
3,299 | $837,847 | |
| 5 | AMGN |
Amgen Inc
|
1,624 | $588,082 | |
| 6 | MRK |
Merck & Co., Inc.
|
3,783 | $486,115 | |
| 7 | PFE |
Pfizer Inc
|
4,666 | $112,357 | |
| 8 | NVS |
Novartis AG
|
562 | $88,076 |
All Filings in LLY
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,119,068 | 933 | Shares | Sole | 2026-07-09 | |
| 2026-03-31 | $836,070 | 909 | Shares | Sole | 2026-04-15 | |
| 2025-12-31 | $1,016,647 | 946 | Shares | Sole | 2026-01-27 | |
| 2025-09-30 | $715,694 | 938 | Shares | Sole | 2025-10-15 | |
| 2025-06-30 | $763,159 | 979 | Shares | Sole | 2025-07-15 | |
| 2025-03-31 | $804,436 | 974 | Shares | Sole | 2025-04-10 | |
| 2024-12-31 | $789,756 | 1,023 | Shares | Sole | 2025-01-15 | |
| 2024-09-30 | $920,491 | 1,039 | Shares | Sole | 2024-10-24 | |
| 2024-06-30 | $962,418 | 1,063 | Shares | Sole | 2024-07-12 | |
| 2024-03-31 | $930,440 | 1,196 | Shares | Sole | 2024-04-16 | |
| 2023-12-31 | $1,599,532 | 2,744 | Shares | Sole | 2024-01-12 | |
| 2023-09-30 | $1,481,404 | 2,758 | Shares | Sole | 2023-10-13 | |
| 2023-06-30 | $1,269,059 | 2,706 | Shares | Sole | 2023-07-10 | |
| 2023-03-31 | $911,436 | 2,654 | Shares | Sole | 2023-04-13 | |
| 2022-12-31 | $900,332 | 2,461 | Shares | Sole | 2023-01-11 | |
| 2022-09-30 | $669,981 | 2,072 | Shares | Sole | 2022-10-27 | |
| 2022-06-30 | $673,101 | 2,076 | Shares | Sole | 2022-07-12 | |
| 2022-03-31 | $485,397 | 1,695 | Shares | Sole | 2022-04-27 | |
| 2021-12-31 | $451,619 | 1,635 | Shares | Sole | 2022-01-28 | |
| 2021-09-30 | $377,073 | 1,632 | Shares | Sole | 2021-11-02 | |
| 2021-06-30 | $368,379 | 1,605 | Shares | Sole | 2021-08-05 | |
| 2021-03-31 | $321,143 | 1,719 | Shares | Sole | 2021-04-26 | |
| 2020-12-31 | $305,600 | 1,810 | Shares | Sole | 2021-02-03 | |
| 2020-09-30 | $267,916 | 1,810 | Shares | Sole | 2020-10-26 | |
| 2020-06-30 | $308,986 | 1,882 | Shares | Sole | 2020-07-21 | |
| 2020-03-31 | $208,080 | 1,500 | Shares | Sole | 2020-04-24 | |
| No filing history on record for this holder in this stock. | ||||||